Blog

Moving beyond compliance, quality culture drives clinical trial innovation through automated processes and measurable results.

A blueprint for engineering elegant eCOA solutions that make complex trials feel simple.

One is very common, the other is rarely granted. Learn the key differences between waiver of consent & waiver of written consent for clinical trials

Discover FDA’s guidance on collecting PROs for Real-World Evidence (RWE), focusing on timing, methods, and improving data quality.

When it comes to Phase 4 clinical trials, Castor’s cutting-edge Real-World Evidence (RWE) platform is your key to unlocking unprecedented insights. Elevate Your Phase 4 Trials with our user-friendly EDC system that adapts to your unique Phase 4 needs. Effortlessly manage multi-region studies with our flexible platform. Reduce costs and accelerate timelines with our innovative AI solutions. Rest easy with our robust security and compliance features.

A deep dive into the evolving regulatory environment, the innovative approaches emerging in RWE, and the critical importance of precise data utilization

A deep dive into the evolving regulatory environment, the innovative approaches emerging in RWE, and the critical importance of precise data utilization

Discover the transformative role of AI in clinical trials, with expert insights from Derk Arts and MaryAnne Rizk on ethical and efficient drug development

The Evolving Landscape of eCOA in Clinical Trials Clinical trials have long grappled with the complexities of data…

Meet the team at booth #2327 at DIA to discuss your RWE needs, get a demo and see our newest human-in-the loop AI capability in action.